Pretreatment with Esketamine Reduces Etomidate-Induced Myoclonus During the Induction of Anesthesia: A Randomized Controlled Trial
Esketamine 0.1mg/kg IV pretreatment significantly reduce the incidence and the severity of severe myoclonus of etomidate-induced myoclonus without significant adverse effects.
Authors
- J.-Y Wang (ORCID: https://orcid.org/0000-0002-1660-7777)
- Mengmeng Zhu (ORCID: https://orcid.org/0000-0002-5161-813X)
- Yuanyuan Cao (ORCID: https://orcid.org/0000-0002-3146-3871)
- Lei Zhang (ORCID: https://orcid.org/0000-0001-7769-7377)
- Lijian Chen (ORCID: https://orcid.org/0000-0003-0627-1138)
Institutions
- Anhui Medical University (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- Therapeutics and Clinical Risk Management
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/tcrm.s485626
- Citations
- 2
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.77